Cryonics as Cause Area
TLDR: Cryonics should be considered as part of a diversified portfolio of altruistic projects. I estimate, using ~ 3% chance of revival and a modest post-revival lifespan (~20,000 years), that current biopreservation is roughly on par with top GiveWell charities in terms of QALYs per dollar. Scaled up, it could plausibly be dozens of times better . There are various complications, of course, but it still seems reasonable that cryonics complements rather than competes with things like AI-safety work. It may even ease pressure to race toward superintelligence as people’s only hope of not dying. Meta: I’m Max Harms, long-time researcher at MIRI, [1] rationalist, EA, and cryonics enthusiast. After doing a deep-dive on Nectome , a brain preservation startup, they hired me to write some additional pieces on cryonics (by which I mean both “traditional cryonics” and the aldehyde-based preservation used by Nectome). [2] The ideas in this essay are ones I have believed for many years, and I was the one who pitched the idea to Nectome. Part 1: Diversification Common wisdom in investment circles is to have a diversified portfolio — to not put all your eggs in one basket. This is wise for two reasons: Money is not utility. The difference between being broke and having a million dollars is much, much bigger than the difference between having 100 million and 101 million. Double-or-nothing usually has negative expected value, even if it’s neutral in expected money. We often assume that huma…